No abstract available
MeSH terms
-
Administration, Oral
-
Aged
-
Anilides / adverse effects*
-
Anilides / therapeutic use
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Carcinoma, Basal Cell / drug therapy*
-
Carcinoma, Basal Cell / pathology
-
Cohort Studies
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Follow-Up Studies
-
France
-
Humans
-
Male
-
Middle Aged
-
Prospective Studies
-
Pyridines / adverse effects*
-
Pyridines / therapeutic use
-
Risk Assessment
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / pathology
-
Spasm / chemically induced*
-
Spasm / physiopathology
-
Withholding Treatment
Substances
-
Anilides
-
Antineoplastic Agents
-
HhAntag691
-
Pyridines